医药行业持续快速增长（The pharmaceutical industry sustained rapid growth）.docVIP

医药行业持续快速增长（The pharmaceutical industry sustained rapid growth） SARS period, the pharmaceutical industry has become the most prominent focus of the industry, while the international VC prices since the second half of last year has continued to rise, so that the relevant production enterprises benefit greatly. In the prediction of the economic operation in 2003 the main industry, the smaller the pharmaceutical industry is considered the fastest growth, profit growth is expected to 20%, way ahead of other industries, in advocating the value investment idea today, need to pay attention to. Pharmaceutical business is still squeezed Pharmaceutical manufacturing grew by more than 20% In 2003, the national economic and Trade Commission issued a forecast for the major sectors of the economy. The smaller pharmaceutical industry was the fastest growing, with an expected profit growth of 20%, far ahead of other industries. According to the statistics, from January to April, the pharmaceutical industry sales revenue increased by 24.4%, gross profit increased by 43.7%, far higher than the expected. Although the total value of the profits has fluctuated substantially over the year, it is not appropriate to push it directly to the full year. But we believe that the growth of revenue and profits of pharmaceutical manufacturing in 2003 over 20% should be achieved. SARS has limited influence on this year Although from November last year, the first patient appeared since the SARS lasted in Chinese before and after about 7 months, but the associated retail drug peak consumption, especially the prevention of drug consumption peak period is not long, area is limited, mainly concentrated in the first half of February around Guangdong and in late April in Beijing and the surrounding. In addition, due to the SARS patients are not many, a total of about more than 5000 cases, and to support the treatment of antiviral drugs (such as Leigh Bhave Lin), antibiotics (roxithromycin) and glucocortico